Trial Profile
Lamictal [lamotrigine] as add on treatment in mixed states of bipolar disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 19 Jun 2012 Actual patient number is 28 according to ClinicalTrials.gov.
- 19 Jun 2012 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.